MARKET

IFRX

IFRX

Inflarx
NASDAQ
2.120
+0.010
+0.47%
After Hours: 2.100 -0.02 -0.94% 17:53 07/07 EDT
OPEN
2.130
PREV CLOSE
2.110
HIGH
2.330
LOW
2.041
VOLUME
1.23M
TURNOVER
--
52 WEEK HIGH
2.949
52 WEEK LOW
0.7406
MARKET CAP
312.26M
P/E (TTM)
-2.9506
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IFRX last week (0629-0703)?
Weekly Report · 1d ago
Strong Buy at under $10: The highest Quant-rated bargain stocks right now
Seeking Alpha · 4d ago
InflaRx Moves to Broaden AAV Strategy in Europe After EMA Setback for Tavneos
TipRanks · 06/30 20:28
InflaRx (IFRX) Gets a Buy from Oppenheimer
TipRanks · 06/30 12:15
InflaRx Mulls Feasibility For AAV In Europe
Benzinga · 06/30 11:37
InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos
Barchart · 06/30 06:30
Weekly Report: what happened at IFRX last week (0622-0626)?
Weekly Report · 06/29 09:10
Strength Seen in Kymera Therapeutics (KYMR): Can Its 16.6% Jump Turn into More Strength?
NASDAQ · 06/26 09:16
More
About IFRX
Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory diseases. Its lead product candidate, IFX-1, is an intravenously delivered first-in-class anti-C5a monoclonal antibody, undergoing Phase II clinical trial for the treatment of Hidradenitis Suppurativa (HS), a rare and chronic debilitating systemic inflammatory skin disease, and entering Phase II clinical trial for the treatment of ANCA-associated vasculitis (AAV) and other rare autoimmune diseases. The Company's product pipeline also includes IFX-2, which is in preclinical development.

Webull offers Inflarx NV stock information, including NASDAQ: IFRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IFRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IFRX stock methods without spending real money on the virtual paper trading platform.